Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Lo Nigro

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2002
Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6Leslie J Raffini, Diana J Slater, Eric F Rappaport, et al.
International Journal of Molecular Sciences|April 30, 2021
NUP-98 Rearrangements Led to the Identification of Candidate Biomarkers for Primary Induction Failure in Pediatric Acute Myeloid LeukemiaVincenza Barresi, Virginia Di Bella, Nellina Andriano, et al.
Genes, Chromosomes & Cancer|September 23, 2008
Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarksSilvia Bungaro, Marta Campo Dell'Orto, Andrea Zangrando, et al.
Pediatric Blood & Cancer|December 9, 2008
Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?Marinella Veltroni, Laura Sainati, Marco Zecca, et al.
Frontiers in Immunology|October 9, 2023
Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experienceAndrea Duminuco, Uros Markovic, Nunziatina Laura Parrinello, et al.
Biochemical Pharmacology|August 17, 2023
MiR-146a-5p enrichment in small-extracellular vesicles of relapsed pediatric ALCL patients promotes macrophages infiltration and differentiationAnna Garbin, Giorgia Contarini, Carlotta C Damanti, et al.
Haematologica|September 13, 2005
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 studyMaurizio Aricò, Valentino Conter, Maria Grazia Valsecchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemiaAndrea Pession, Maria Grazia Valsecchi, Giuseppe Masera, et al.
Oncotarget|January 4, 2018
Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphomaElena Pomari, Federica Lovisa, Elisa Carraro, et al.
Cancers|May 28, 2022
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)Luca Lo Nigro, Nellina Andriano, Barbara Buldini, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2002
Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6Leslie J Raffini, Diana J Slater, Eric F Rappaport, et al.
International Journal of Molecular Sciences|April 30, 2021
NUP-98 Rearrangements Led to the Identification of Candidate Biomarkers for Primary Induction Failure in Pediatric Acute Myeloid LeukemiaVincenza Barresi, Virginia Di Bella, Nellina Andriano, et al.
Genes, Chromosomes & Cancer|September 23, 2008
Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarksSilvia Bungaro, Marta Campo Dell'Orto, Andrea Zangrando, et al.
Pediatric Blood & Cancer|December 9, 2008
Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?Marinella Veltroni, Laura Sainati, Marco Zecca, et al.
Frontiers in Immunology|October 9, 2023
Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experienceAndrea Duminuco, Uros Markovic, Nunziatina Laura Parrinello, et al.
Biochemical Pharmacology|August 17, 2023
MiR-146a-5p enrichment in small-extracellular vesicles of relapsed pediatric ALCL patients promotes macrophages infiltration and differentiationAnna Garbin, Giorgia Contarini, Carlotta C Damanti, et al.
Haematologica|September 13, 2005
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 studyMaurizio Aricò, Valentino Conter, Maria Grazia Valsecchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemiaAndrea Pession, Maria Grazia Valsecchi, Giuseppe Masera, et al.
Oncotarget|January 4, 2018
Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphomaElena Pomari, Federica Lovisa, Elisa Carraro, et al.
Cancers|May 28, 2022
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)Luca Lo Nigro, Nellina Andriano, Barbara Buldini, et al.
Pageof 7